1. Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 2 November 2011 Prescription Drug…
Slide 1Pharmacological Treatment of Addiction David A. Fiellin, M.D. Professor of Medicine Yale University School of Medicine Slide 2 Overview Epidemiology of opioid dependence…
Naloxone Training Program EMR/EMT May 27, 2014 State of Connecticut Department of Public Health/OEMS * Goal To reduce mortality and morbidity from opioid overdose by instructing…
Naloxone Training Program EMR/EMT May 27, 2014 State of Connecticut Department of Public Health/OEMS * Goal To reduce mortality and morbidity from opioid overdose by instructing…
1. Opioid Harm Reduction Strategies Paul C. Coelho, MD Board Certified PM&R Subspecialty Certified Pain Medicine 2. Table Of Contents 1. Reducing Harms to High Dose Patients…
1 ATTORNEY GENERAL OF THE STATE OF NEW YORK In the Matter of Purdue Pharma L.P. Assurance No.: 15-151 ASSURANCE OF DISCONTINUANCE UNDER EXECUTIVE LAW SECTION 63, SUBDIVISION…
Slide 1Pain Management Updates and Issues Robert Twillman, PhD The University of Kansas Medical Center Slide 2 Pain is a major public health issue 80% of patients present…
Slide 1Defining Non-Medical Use of Prescription Opioids within Health Care Claims: A Systematic Review Gerald Cochran, PhD 1,2 Bongki Woo, MSW 3 Wei-Hsuan Lo-Ciganic, PhD,…